Sanofi Consumer Healthcare India Limited — Updates, 01-05-2025: Press Release

Sanofi has announced a board meeting on the financial results for the quarter and half-year. It completed the sale of a 50% controlling stake in its consumer healthcare unit Opella to CD&R, retaining a 48.2% stake. The transaction generated net cash proceeds of around €10 billion. Post-sale, Sanofi will focus exclusively on biopharma, while Opella aims to grow independently in consumer healthcare with over 11,000 employees and a global presence.